Article Details
Retrieved on: 2022-08-04 15:15:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Drugmaker AstraZeneca's Lynparza has received European Union approval for use in the adjuvant treatment of adult patients with high-risk ...
Article found on: www.sharecast.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here